159 related articles for article (PubMed ID: 31921886)
1.
Schönburg S; Bauer W; Mohammed N; Brössner C; Fornara P
Front Surg; 2019; 6():72. PubMed ID: 31921886
[No Abstract] [Full Text] [Related]
2. Complications of the urinary incontinence system ATOMS: description of risk factors and how to prevent these pitfalls.
Mühlstädt S; Angulo JC; Mohammed N; Schumann A; Fornara P
World J Urol; 2020 Jul; 38(7):1795-1803. PubMed ID: 31542824
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for persistent, de novo and overall overactive bladder syndrome after surgical prolapse repair.
Frigerio M; Manodoro S; Cola A; Palmieri S; Spelzini F; Milani R
Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():141-145. PubMed ID: 30597338
[TBL] [Abstract][Full Text] [Related]
4. Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence.
Ko KJ; Lee CU; Kim TH; Suh YS; Lee KS
Urology; 2018 Mar; 113():215-219. PubMed ID: 29030076
[TBL] [Abstract][Full Text] [Related]
5. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of urodynamic characteristics between female patients with overactive bladder and overactive bladder plus stress urinary incontinence.
Lin LY; Yeh NH; Lin CY; Sheu BC; Lin HH
Urology; 2004 Nov; 64(5):945-9. PubMed ID: 15533483
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy.
Virseda-Chamorro M; Téllez C; Salinas-Casado J; Szczesniewski J; Ruiz-Grana S; Arance I; Angulo JC
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137573
[TBL] [Abstract][Full Text] [Related]
8. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.
Baessler K; Christmann-Schmid C; Maher C; Haya N; Crawford TJ; Brown J
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013108. PubMed ID: 30121956
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
10. Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.
Marcelissen T; Van Kerrebroeck P
Neurourol Urodyn; 2018 Jan; 37(1):83-88. PubMed ID: 28631830
[TBL] [Abstract][Full Text] [Related]
11. De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy.
Matsukawa Y; Yoshino Y; Ishida S; Fujita T; Majima T; Funahashi Y; Sassa N; Kato M; Gotoh M
Neurourol Urodyn; 2018 Aug; 37(6):2008-2014. PubMed ID: 29635709
[TBL] [Abstract][Full Text] [Related]
12. Use of free uroflowmetry vs pressure-flow studies in the diagnosis of overactive bladder syndrome in females.
Nowakowski Ł; Futyma K; Ziętek A; Bogusiewicz M; Gałczyński K; Rechberger T
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():137-140. PubMed ID: 27852010
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
[TBL] [Abstract][Full Text] [Related]
15. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
16. Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery.
Liang CC; Hsieh WC; Huang L
Int Urogynecol J; 2017 Apr; 28(4):605-611. PubMed ID: 27678141
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery.
Miotla P; Futyma K; Cartwright R; Bogusiewicz M; Skorupska K; Markut-Miotla E; Rechberger T
Int Urogynecol J; 2016 Mar; 27(3):393-8. PubMed ID: 26364180
[TBL] [Abstract][Full Text] [Related]
18. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
[TBL] [Abstract][Full Text] [Related]
19. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
20. Role of urodynamics in stress urinary incontinence: A critical appraisal.
Yande SD; Joglekar OV; Joshi M
J Midlife Health; 2016; 7(3):119-125. PubMed ID: 27721639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
